Circuit Fabology Microelectronics Equipment Co., Ltd., known by its acronym CFMEE, has launched a Hong Kong IPO targeting approximately HKD 3.07 billion (around USD 395 million), adding a new name to the growing roster of Chinese semiconductor equipment companies seeking dual listings as the US-China tech war reshapes global capital markets. The offering, which opened on June 17 and runs through June 23, is priced at between HKD 240.09 and HKD 252.73 per share, with listing on the Hong Kong Stock Exchange expected on June 26.
CFMEE already trades on Shanghai’s STAR Market under the ticker 688630.SH, where it carries a market capitalization of approximately CNY 46 billion. The Hong Kong listing is under the ticker 09630.HK is designed to broaden the company’s investor base and raise capital for the next phase of its product development at a moment when demand for domestic semiconductor manufacturing equipment in China is growing rapidly.
What CFMEE Makes
The company’s core product is direct-write lithography equipment, also called direct imaging equipment, a category of semiconductor manufacturing equipment used in the production of integrated circuit mask plates, MEMS chips, flat panel displays, advanced packaging, and printed circuit boards. Direct-write lithography uses a laser or electron beam to write circuit patterns directly onto a substrate, eliminating the need for a physical mask and offering flexibility and precision advantages in certain applications.
CFMEE holds the distinction of being the first to produce China’s domestically manufactured direct-write lithography equipment, and it drafted the national standard GB/T 43725-2024 for the category. That standard-setting role reflects the company’s position at the top of its domestic market — a position that has become strategically significant as China works to reduce its dependence on imported semiconductor manufacturing equipment.
The company’s revenue for the trailing twelve months to March 2026 was approximately USD 237 million, with net income of roughly CNY 290 million. Revenue for the full year 2025 was approximately USD 245 million.
A Strong Cornerstone Book
The IPO has attracted 17 cornerstone investors, a number that signals strong institutional confidence in the offering. The cornerstone book includes Hefei SASAC, the state-owned assets supervision commission of Hefei, where CFMEE is headquartered, as well as Hillhouse Capital’s HHLRA vehicle, Montage Technology, Tongfu Microelectronics, and Sungrow Power. Together, the cornerstone investors have subscribed to approximately 6.4 million shares, representing around USD 202 million at the mid-point of the price range.
The presence of Hillhouse Capital is notable. The Beijing-based private equity firm is one of China’s most prominent institutional investors, with a track record of backing technology companies at inflection points in their development. Its participation in the CFMEE cornerstone book is a signal that the company’s growth trajectory is viewed as credible by sophisticated investors who have access to detailed financial and operational information.
The sole sponsor for the listing is CICC, China International Capital Corporation, which has been the lead bank on a significant proportion of Chinese technology IPOs in recent years.
The Broader Context
CFMEE’s Hong Kong listing is part of a wave of Chinese semiconductor equipment and chip companies seeking dual listings that EastFrontier has been tracking throughout 2026. The pattern reflects a deliberate strategy by Chinese technology companies to access international capital while maintaining their domestic listing, a dual-track approach that provides both funding flexibility and a degree of insulation from the volatility that can affect either market independently.
For Hong Kong, the continued flow of Chinese technology IPOs has been a significant source of activity amid an otherwise challenging environment for global equity markets. EastFrontier previously reported on the city’s IPO market hitting a five-year high in Q1 2026, led by AI companies including Zhipu and MiniMax. CFMEE’s listing extends that momentum into the semiconductor equipment sector.
The strategic significance of direct-write lithography equipment in China’s semiconductor independence narrative should not be underestimated. While the category does not attract the same attention as EUV lithography, the technology that China cannot currently produce or import, it is a critical component of the broader semiconductor manufacturing ecosystem, and CFMEE’s position as the domestic leader in the category makes it a beneficiary of the same policy tailwinds that have driven investment across China’s chip supply chain.
The Independence Narrative
For investors assessing CFMEE’s long-term prospects, the most important context is not the company’s current revenue or market capitalization, it is the policy environment in which it operates. China’s semiconductor equipment sector has been identified as one of the highest-priority areas for domestic substitution, with the government providing a combination of procurement preferences, R&D subsidies, and regulatory support to accelerate the replacement of imported equipment with domestic alternatives.
The direct-write lithography segment is a relatively small part of the overall semiconductor equipment market, but it is strategically important. The ability to produce mask plates domestically, rather than relying on imported equipment from companies like Heidelberg Instruments or Mycronic, reduces a vulnerability in China’s chip supply chain that has received less attention than the EUV lithography gap but is no less real. CFMEE’s national standard-setting role gives it a degree of institutional embeddedness in the domestic market that competitors find difficult to replicate.
The Hong Kong listing will also give CFMEE access to international institutional investors who have been showing growing interest in China’s semiconductor equipment sector. The combination of policy tailwinds, a dominant domestic market position, and a credible technology roadmap makes the company a representative example of the investment thesis that has driven capital into Chinese chip-related companies throughout 2025 and 2026. Whether the IPO pricing reflects that thesis fairly will be tested when the stock begins trading on June 26.